Literature DB >> 12591367

Equoral, new cyclosporine drug delivery system, versus neoral: a bioequivalence study in healthy volunteers.

T Andrysek1, M Masri, A Jegorov, Z Veselsky, V Matha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12591367     DOI： 10.1016/s0041-1345(02)03924-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun.

Authors:  F Kees; M Bucher; F Schweda; H Gschaidmeier; L Faerber; R Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-15       Impact factor: 3.195

2.  Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants.

Authors:  Anja Gäckler; Sebastian Dolff; Hana Rohn; Johannes Korth; Benjamin Wilde; Ute Eisenberger; Anna Mitchell; Andreas Kribben; Oliver Witzke
Journal:  BMC Nephrol       Date:  2019-05-14       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.